Physician profile
Emily B Rose
NPI 1699793117
$62,326.23
in general payments reported to CMS, 2019-2025
24 companies · $2,913 in 2025
The $2,913 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,955 · 2020: $2,936 · 2021: $12K · 2022: $8,660 · 2023: $16K · 2024: $11K · 2025: $2,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Food and Beverage: $4,812 · Travel and Lodging: $4,185 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,849.34 |
| Food and Beverage | $4,811.57 |
| Travel and Lodging | $4,185.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $29,761.67 | 2019-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Boston Scientific Corporation | $10,805.19 | 2019-2025 | Watchman Access System, Watchman Flx, Cds - Mct/Cem Monitoring |
| Pfizer INC. | $8,653.80 | 2019-2025 | |
| Medical Device Business Services, INC. | $6,508.37 | 2019-2023 | Carto 3 |
| Abbott Laboratories | $3,128.50 | 2019-2025 | Aveir, Gallant, Ensite Precision |
| Medtronic, INC. | $2,571.14 | 2021-2025 | Micra, Linq II, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $338.86 | 2019-2024 | Selectra, Acticor 7 Vr-T Dx |
| Cardiva Medical, INC. | $102.64 | 2023-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Optowire, Cardiva Vascade Mvp Vvcs 6-12f |
| Penumbra, INC. | $60.84 | 2023-2024 | Indigo System, Penumbra System |
| Philips North America LLC | $55.27 | 2022-2025 | Lm Undivided |
| Cardiovascular Systems INC. | $46.64 | 2019-2020 | |
| Irhythm Technologies, INC. | $36.00 | 2024 | Zio Xt Patch, Zio Monitor |
| Elutia, INC. | $34.01 | 2022-2024 | Ecm Patch,Pouch |
| Teleflex LLC | $29.32 | 2025 | Guideliner |
| Becton, Dickinson and Company | $25.58 | 2025 | Hemosphere |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.96 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.53 | 2023 | Jardiance |
| Edwards Lifesciences Corporation | $21.23 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $19.75 | 2025 | Camzyos |
| Lexicon Pharmaceuticals, INC. | $18.47 | 2024 | |
| Cordis US Corp. | $16.94 | 2024 | Mynx Venous Vcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.46 | 2025 | Lifevest |
| Chiesi USA, INC. | $15.75 | 2025 | Cleviprex, Kengreal |
| Medtronic Vascular, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.